DOCSLIB.ORG

SCIENTIFIC CONGRESS INSIDE This Program OPENING CEREMONY

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SCIENTIFIC CONGRESS INSIDE This Program OPENING CEREMONY SCIENTIFIC CONGRESS INSIDE this program OPENING CEREMONY. 2 ASRM WELCOME ................. 3 HOTEL INFORMATION ............ 5 ASRM SCIENTIFIC CONGRESS PLANNING COMMITTEES ........7-9 ASRM OFFICERS AND BOARD OF DIRECTORS ........... 7 2016 AWARDS ............... 10-23 ASRM SCIENTIFIC CONGRESS POLICIES AND DISCLAIMERS .....24 MEMBERS' MEETINGS ...........26 CME/CE SECTION ...............27 EDUCATIONAL SUPPORT ........28 CONTINUING MEDICAL EDUCATION CONTINUING EDUCATION. 30, 31 PRE-CONGRESS PROGRAM ... 32-50 JOIN US FOR OUR NON-CME ACTIVITIES ............51 ASRM 5K RUN INFORMATION .....51 NEEDS ASSESSMENT AND Opening Ceremony LEARNING OBJECTIVES ..........52 ASRM 2016 CONGRESS GRID .....53 SCIENTIFIC CONGRESS Monday, October 17th, 8:00 am – 9:00 am DAILY SCHEDULE ............. 54-62 in the Salt Palace Convention Center Ballroom 2016 NICHD-ASRM WORKSHOP ..63 TRACKS GRID ............... 64-66 Come hear ASRM President, Dr. Owen Davis, discuss CONTRACEPTION TRACK ........67 the Society's accomplishments this year and plans for MENOPAUSE TRACK .............68 SURGERY TRACK ............. 69,70 "Scaling New Heights in Reproductive Medicine." ART TRACK .................. 71,72 FIBROIDS TRACK ...............73 Plenary 1 will immediately follow in the same room. ENDOMETRIOSIS TRACK ........74 GENETICS TRACK ...............75 A continental breakfast will be available RESIDENT REPORTER TRACK. 76 7:00 am – 8:00 am PLENARY SESSIONS .......... 77-81 LECTURES ......................82 Ballroom – North Foyer SYMPOSIA ................... 83-98 INTERACTIVE SESSIONS .....99-110 ADDITIONAL SESSIONS .....111-114 NON-CME SECTION ............115 VIDEO SESSIONS ...........116-124 ROUNDTABLES ............125-130 ASRM IS PAPERLESS ............130 FUTURE MEETINGS ............130 ABSTRACT REVIEW COMMITTEES ..............131,132 ORAL PRESENTATIONS .....133-164 POSTER PRESENTATIONS ...165-235 ABSTRACT TOPIC INDEX ....236-238 ABSTRACT AUTHOR INDEX ..239-266 SPEAKERS INDEX ..........267-269 DISCLOSURES .............270-288 ASRM 2O16 SCIENTIFIC CONGRESS Welcome practice and laboratory managers, as well as scientific abstract presentations, representing specialists in mental health, law, and ethics, cutting-edge research in reproductive in order to advance the highest standards of medicine and biology. Dr. Schattman and medical care and to disseminate the latest the Pre-Congress Program Committee have developments in clinical and basic research. collaborated with our affiliated societies Dr. Clarisa Gracia, Chair of the Scientific and professional and special interest Congress Committee, Dr. Glenn Schattman, groups to present a stimulating array of Chair of the Pre-Congress Program Pre-Congress courses that will meet the Committee, and members of their organizing needs of our clinicians, scientists, laboratory It gives me great pleasure to teams have designed an outstanding and technologists, nurses, and other health-care welcome you to the beautiful provocative program for all of our members. and allied professionals. setting of Salt Lake City, Utah, for the 2016 American Society for The Continuing Medical Education (CME)/ We welcome our members and trainees Reproductive Medicine Scientific Continuing Education (CE) portion of the as well as our colleagues from around nd Congress & Expo, our 72 Scientific Congress will include an exciting the world to attend and engage in the Scientific Congress & Expo. This array of plenary lectures, symposia, and ASRM Scientific Congress & Expo. As year’s Congress theme is “Scaling interactive sessions, all interweaving the always, we value the participation of New Heights in Reproductive theme of the Congress. Topics range from the our global community, including the Medicine,” and will encompass impact of environmental factors and stress on symposia organized and presented by our all aspects of reproductive reproductive health, to reproductive genetics international sister societies. The meeting medicine, technology, and and epigenetics, endocrinology, global access will offer extensive opportunities for our health. The program will be a to reproductive care, reproductive and fetal attendees to network and interact, including comprehensive and stimulating surgery, optimization of assisted reproductive an enjoyable social program. I look forward balance between an exploration technology outcomes, fertility preservation, to seeing you in stunning Salt Lake City of the latest molecular and and contraceptive technology. The where together we will be “Scaling New genetic techniques and how interactive sessions focus on a wide range Heights in Reproductive Medicine.” reproduction affects public of controversial topics and are designed health on a global scale. This to energize and stimulate discussion and live program is intended to serve interaction among the participants. The Sincerely, the needs of physicians, nurses, CME program will be complemented by andrology and embryology non-CME activities, including intimate, in- laboratory personnel, genetic depth roundtable luncheons with recognized Owen K. Davis, M.D. counselors, social workers, experts, in addition to oral and poster-format ASRM President, 2015-2016 nd 72 ASRM Scientific Congress & Expo 3 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Salt LakeWELCOME TO City Salt Lake is a city of unexpected surprises and brims with history, art, culture, entertainment, and recreation—all in a beautiful location at the foot of Utah's Wasatch Mountains. Salt Lake combines the amenities of a large metro area with the opportunity to take advantage of year-round outdoor recreation within minutes in every direction. An attractive, safe, and growing city, Salt Lake offers unequaled views, a thriving economy, exciting nightlife, remarkable history, the warm hospitality of a small western town, and "The Greatest Snow on Earth™". Salt Lake is an incredible destination for patrons of the performing arts with: Ballet West, Utah Opera Company, Ririe- Woodbury Dance Company, Repertory Dance Theatre, Mormon Tabernacle Choir, and The Utah Symphony. Numerous theater groups and over 20 art galleries are within minutes of Salt Lake's downtown hotels. nd 72 ASRM Scientific Congress & Expo 4 Salt Lake City, Utah slctravel.com of courtesy Information l t C a p i t o a s E Pioneer UTAH STATE 300 North Memorial CAPITOL Museum . A St B St C St a n y o n R d Memory Grove Council C ASRM 2O16 SCIENTIFIC CONGRESS Hall 500 West 400 West 300 West 200 West 4th Ave. 200 North p Conference North Temple Center 3rd Ave. Bridge/Salt Lake City Hotel Information Main St. Guadalupe State St. SALTTRAX LAKE DOWNTOWN ACCOMMODATIONSCity Creek Station West Temple Park 2nd Ave. North Templele to airport — 7 miles TEMPLE SQUARE Brigham Young Museum of Church Historic Park 8 History & Art Tabernacle Joseph Smith Memorial Beehive Building House Family History 1st Ave. First Library Lion Mormon Pioneer Presbyterian THE LDS Temple House Church Arena Temple Square Memorial GATEWAY Monument Union TRAX Station South Temple TRAX Station 4 Olympic Pacific 1 South Temple Legacy Depot Plaza Utah Cathedral 3 Museum of of the Contemporary City Center (100 S) Madeleine EnergySolutions Maurice Cathedral EnergySolutions Abravanel Art TRAX Station Arenaa Church of Hall Harmons Grocery St. Mark Discovery 1 Salt Lake To Go CITY CREEK CITY CREEK Gateway CENTER CENTER Visitor Information 1 1000 SouthSSouthth Center 2 100 South Clark Planetarium Planetarium SALT PALACE 2 TRAX Station N CONVENTION Capitol Theatre CENTER 200 SouthSh 3 200 South Old Greektown Gallivan TRAX Station 9 11 Center 5 Rio Grande Depot & Utah State Pierpont Ave. Pierpont Ave. Gallivan Plaza Historical Museum 2 TRAX Station TRAX / UTA Free Fare Zone 3 KUTV2 Main Street News Studio 300 South 4 300 South S e LINE t PIONEER BLUE PARK , & 400 West to Foothill Cultural District 300 West 200 West est Templ 4 500 West 200 Eas and University of Utah State St. W 1 Main St. Library GREEN 10 TRAX Light Rail — Red Line TRAX Station 400 South 400 South 5 — RED, Salt Lake City & LIBRARY 7 County Building SQUARE 1 Light Rail Court House TRAX Station 5TRAX 2 W ASHINGTON TRAX / UTA Free Fare Zone 15 SQUARE 500 South 6 500 South 1 1210 t 2 14 t 6 400 Eas 31 6 10 300 Eas 600 South 600 South 2 13 117 31 10 42American Society for Reproductive117 Medicine 1 8 700 South 32016 Annual Meeting | Salt Lake City,1012 Utah | October 15-19, 2016 42 11 3151 Salt Lake Marriott Downtown at City Creek 1012 88 Hyatt Place Salt Lake City Downtown 422 Hilton Salt Lake City Center 1311 99 Holiday Inn Express 353 Radisson Hotel Salt Lake City Downtown 1012 10 Fairfield Inn Salt Lake City Downtown (formerly Courtyard) 4624 The Salt Lake Plaza Hotel at Temple Square 1311 119 Hotel Monaco 355 Marriott Salt Lake City Center 1412 12 Little America Hotel & Towers 466 DoubleTree Suites by Hilton 1311 Red Lion Hotel Salt Lake Downtown 3 757 Hampton Inn Salt Lake City Downtown 1412 14 The Grand America Hotel 4 6 1513 15 Sheraton Salt Lake City Hotel 75 1412 468 1513 75 14 68 1513 975 14 nd 72 ASRM Scientific Congress & Expo 5 Salt Lake City, Utah 68 15 97 14 68 15 97 8 15 97 8 9 8 9 9 ASRM 2O16 SCIENTIFIC CONGRESS OCTOBER 17-19, 2016 | SALT LAKE CITY, UT Committees and Awards • ASRM Scientific Congress Program Planning Committee 7 • Society Awards 10-21 • ASRM Star Awards 22, 23 • ASRM Milestone Awards 23 SPONSORED BY THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE ASRM 2O16 SCIENTIFIC CONGRESS ASRM 2016 Scientific Congress ASRM Officers and Program Planning Committee Board of Directors Owen K. Davis, M.D., President 2015 — 2016 Clarisa R. Gracia, M.D., M.S.C.E., Scientific Congress Program Chair ASRM OFFICERS Owen K. Davis, M.D. Interactive Sessions Chair Anne Z. Steiner, M.D., M.P.H., President Anuja Dokras, M.D., Ph.D., Roundtables Chair Richard J. Paulson, M.D. Michael I. Eisenberg, M.D., Ad Hoc Committee Member President-Elect Sharon Covington, M.S.W., L.C.S.W.-C., Ad Hoc Committee Member Christos Coutifaris, M.D., Ph.D. Amy E. T. Sparks, Ph.D., H.C.L.D., Ad Hoc Committee Member Vice President Kevin J. Doody, M.D., H.C.L.D., Society for Assisted Reproductive Rebecca Z. Sokol, M.D., M.P.H. Technology Program Chair Immediate Past President Thomas M.
Load more

Recommended publications
  • Activity of Povidone in Recent Biomedical Applications with Emphasis on Micro- and Nano Drug Delivery Systems
    pharmaceutics Review Activity of Povidone in Recent Biomedical Applications with Emphasis on Micro- and Nano Drug Delivery Systems Ewelina Waleka 1,2 , Zbigniew Stojek 1 and Marcin Karbarz 1,* 1 Faculty of Chemistry, Biological and Chemical Research Center, University of Warsaw, 101 Zwirki˙ i Wigury Av., PL 02-089 Warsaw, Poland; [email protected] (E.W.); [email protected] (Z.S.) 2 Faculty of Chemistry, Warsaw University of Technology, 1 Pl. Politechniki Av., PL 00-661 Warsaw, Poland * Correspondence: [email protected] Abstract: Due to the unwanted toxic properties of some drugs, new efficient methods of protection of the organisms against that toxicity are required. New materials are synthesized to effectively disseminate the active substance without affecting the healthy cells. Thus far, a number of poly- mers have been applied to build novel drug delivery systems. One of interesting polymers for this purpose is povidone, pVP. Contrary to other polymeric materials, the synthesis of povidone nanoparticles can take place under various condition, due to good solubility of this polymer in several organic and inorganic solvents. Moreover, povidone is known as nontoxic, non-carcinogenic, and temperature-insensitive substance. Its flexible design and the presence of various functional groups allow connection with the hydrophobic and hydrophilic drugs. It is worth noting, that pVP is regarded as an ecofriendly substance. Despite wide application of pVP in medicine, it was not often selected for the production of drug carriers. This review article is focused on recent reports on the role povidone can play in micro- and nano drug delivery systems.
    [Show full text]
  • Polyvinylpyrrolidone
    POLYVINYLPYRROLIDONE Prepared at the 30th JECFA (1986), published in FNP 37 (1986) and in FNP 52 (1992). Metals and arsenic specifications revised at the 63rd JECFA (2004). An ADI of 0-50 mg/kg bw was established at the 30th JECFA (1986) SYNONYMS Povidone, PVP; INS No. 1201 DEFINITION Chemical names Polyvinylpyrrolidone, poly-[1-(2-oxo-1-pyrrolidinyl)- ethylene] C.A.S. number 9003-39-8 Chemical formula (C6H9NO)n Structural formula Formula weight Lower molecular weight range product: about 40 000 Higher molecular weight range product: about 360 000 Assay Not less than 12.2% and not more than 13.0% of Nitrogen (N) on the anhydrous basis DESCRIPTION White to tan powder; supplied in two molecular weight forms; the molecular weight value is an average molecular weight for the two forms FUNCTIONAL USES Clarifying agent, stabilizer, bodying agent, tableting adjunct, dispersing agent CHARACTERISTICS IDENTIFICATION Solubility (Vol. 4) Soluble in water, in ethanol and in chloroform; insoluble in ether pH (Vol. 4) 3.0 - 7.0 (5% soln) Precipitate formation To 5 ml of a 1 in 50 solution of the sample add 5 ml of dilute hydrochloric acid TS, 5 ml of water and 2 ml of 1 in 10 solution of potassium dichromate. A yellow precipitate forms. Add 5 ml of a 1 in 50 solution of the sample to 75 mg of cobalt nitrate and 0.3 g of ammonium thiocyanate dissolved in 2 ml of water, mix and acidify with dilute hydrochloric acid TS. A pale blue precipitate forms. To 5 ml of a 1 in 50 solution of the sample add 1 ml of 25% hydrochloric acid and 5 ml of 5% barium chloride solution and 1 ml of 5% phosphomolybdotungstic acid solution.
    [Show full text]
  • Agrimer™ Polyvinylpyyrolidone (PVP)
    agrimer ™ polyvinylpyyrolidone (PVP) binder, dispersant rheology, modifier, film former, complexing agent Agrimer™ polyvinylpyrrolidone (PVP) this brochure is divided into two main segments suggested applications General properties and uses 2-10 ¢ complexing agent Agricultural case studies 10 ¢ stabilizers / co-dispersants These case studies highlight the uses of Agrimer™ ¢ binders in dry / wet granulation and extrusion (dry compaction / fluidized-bed spray drying process) polymers in seed coatings, granule and tablet binders and as dispersants. ¢ film-forming agents / binders in seed coatings, dips and pour-ons general properties and uses ¢ biological stabilization ¢ water binding / anti-transpiration properties Agrimer™ PVP products are linear, non-ionic polymers that are soluble in water and many organic solvents. ¢ solubility enhancers via co-precipitation or They are pH stable, and have adhesive, cohesive thermal extrusion and binding properties. The unique ability to adsorb ¢ dye-binding agent on a host of active ingredients makes Agrimer™ PVP regulatory status homopolymers preferred co-dispersants in many The Agrimer™ PVP products listed in this brochure are formulations. Agrimer™ homopolymers have a high exempt from the requirement of a tolerance under glass transition temperature. 40 CFR 180.960. Lower molecular weight (Mw) Agrimer™ polymers (Agrimer™ 15 and Agrimer™ 30) are suitable for physical and chemical properties applications where dusting is a concern, such as The Agrimer™ polymers, a family of homopolymers of seed coatings and agglomeration. Higher Mw polyvinylpyrrolidone, are available in different viscosity Agrimer™ polymers (Agrimer™ 90 and Agrimer™ 120) can grades, ranging from very low to very high molecular build formulation viscosity faster and provide excellent weight. This range, coupled with their solubility in binding and film forming properties.
    [Show full text]
  • Investigation of Poly(Vinyl Pyrrolidone) in Methanol by Dynamic Light Scattering and Viscosity Techniques
    http://www.e-polymers.org e-Polymers 2007, no. 020 ISSN 1618-7229 Investigation of Poly(vinyl pyrrolidone) in methanol by dynamic light scattering and viscosity techniques Adel Aschi*, Mohamed Mondher Jebari and Abdelhafidh Gharbi Laboratoire de Physique de la Matière Molle, Faculté des Sciences de Tunis, Campus Universitaire, 1060, Tunisia; Fax +216.71.885.073; email : aschi13@ yahoo.fr (Received: 17 November, 2006; published: 16 February, 2007) Abstract: The behavior of poly(vinyl pyrrolidone) (PVP) in methanol was examined using several independent methods. The hydrodynamic radius (Rh) of individual samples, over a range of molecular weights (10,000–360,000), was determined using dynamic light scattering (DLS) measurements. Dynamic Light Scattering (DLS) techniques directly probe such dynamics by monitoring and analyzing the pattern of fluctuations of the light scattered from polymer molecules. Some viscosity measurements were also performed to complete the DLS measurements and to provide more information on the particle structure. The results obtained with PVP–methanol system showed that plotting the variation of intrinsic viscosity versus the logarithm of the molecular mass of this polymer, we observe one crossover point. This crossover point appears when we reach the Θ-solvent behavior and delimit two molecular mass regions. The second order least-squares regression was used as an approach and was in excellent agreement with viscometric experimental results. Keywords: DLS, Hydrodynamic radius, intrinsic viscosity. Introduction Polymers are frequently employed in many industrial and pharmaceutical applications. As a result, this has prompted a large volume of fundamental studies to understand the kinetic equilibrium, structural, and rheological properties of many different systems.
    [Show full text]
  • Trade Names and Manufacturers
    Appendix I Trade names and manufacturers In this appendix, some trade names of various polymeric materials are listed. The list is intended to cover the better known names but it is by no means exhaustive. It should be noted that the names given may or may not be registered. Trade name Polymer Manufacturer Abson ABS polymers B.F. Goodrich Chemical Co. Acrilan Polyacrylonitrile Chemstrand Corp. Acrylite Poly(methyl methacrylate) American Cyanamid Co. Adiprene Polyurethanes E.I. du Pont de Nemours & Co. Afcoryl ABS polymers Pechiney-Saint-Gobain Alathon Polyethylene E.I. du Pont de Nemours & Co. Alkathene Polyethylene Imperial Chemical Industries Ltd. Alloprene Chlorinated natural rubber Imperial Chemical Industries Ltd. Ameripol cis-1 ,4-Polyisoprene B.F. Goodrich Chemical Co. Araldite Epoxy resins Ciba (A.R.L.) Ltd. Arnel Cellulose triacetate Celanese Corp. Arnite Poly(ethylene terephthalate) Algemene Kunstzijde Unie N.Y. Baypren Polychloroprene Farbenfabriken Bayer AG Beetle Urea-formaldehyde resins British Industrial Plastics Ltd. Ben vic Poly(vinyl chloride) Solvay & Cie S.A. Bexphane Polypropylene Bakelite Xylonite Ltd. Butacite Poly( vinyl butyral) E.I. du Pont de Nemours & Co. Butakon Butadiene copolymers Imperial Chemical Industries Ltd. Butaprene Styrene-butadiene copolymers Firestone Tire and Rubber Co. Butvar Poly(vinyl butyral) Shawinigan Resins Corp. Cap ran Nylon 6 Allied Chemical Corp. Carbowax Poly(ethylene oxide) Union Carbide Corp. Cariflex I cis-1 ,4-Polyisoprene Shell Chemical Co. Ltd. Carina Poly(vinyl chloride) Shell Chemical Co. Ltd. TRADE NAMES AND MANUFACTURERS 457 Trade name Polymer Manufacturer Carin ex Polystyrene Shell Chemical Co. Ltd. Celcon Formaldehyde copolymer Celanese Plastics Co. Cellosize Hydroxyethylcellulose Union Carbide Corp.
    [Show full text]
  • Exfoliation of Graphite with Deep Eutectic Solvents
    (19) TZZ¥ZZ_T (11) EP 3 050 844 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 153(4) EPC (43) Date of publication: (51) Int Cl.: 03.08.2016 Bulletin 2016/31 C01B 31/00 (2006.01) B82Y 30/00 (2011.01) (21) Application number: 14849900.7 (86) International application number: PCT/ES2014/070652 (22) Date of filing: 12.08.2014 (87) International publication number: WO 2015/044478 (02.04.2015 Gazette 2015/13) (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • DE MIGUEL TURULLOIS, Irene GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 28006 Madrid (ES) PL PT RO RS SE SI SK SM TR • HERRADÓN GARCÍA, Bernardo Designated Extension States: 28006 Madrid (ES) BA ME • MANN MORALES, Enrique Alejandro 28006 Madrid (ES) (30) Priority: 24.09.2013 ES 201331382 • MORALES BERGAS, Enrique 28006 Madrid (ES) (71) Applicant: Consejo Superior de Investigaciones Cientificas (74) Representative: Cueto, Sénida (CSIC) SP3 Patents S.L. 28006 Madrid (ES) Los Madroños, 23 28891 Velilla de San Antonio (ES) (54) EXFOLIATION OF GRAPHITE WITH DEEP EUTECTIC SOLVENTS (57) The invention relate to graphite materials, and more specifically to the exfoliation of graphite using deep eutectic solvents, to methods related thereto, to polymer- ic composite materials containing graphene and the methodsfor the production thereof, andto graphene/met- al, exfoliated graphite/metal, graphene/metal oxide and exfoliated graphite/metal oxide composite materials and the methods for the production thereof. EP 3 050 844 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 050 844 A1 Description Field of the Invention 5 [0001] The present invention relates to graphitic materials, and more specifically to exfoliation of graphite using deep eutectic solvents, methods related to it, polymeric composites with exfoliated graphite/graphene, composites graph- ene/metal, exfoliated graphite/metal, graphene/metal oxide and exfoliated graphite/metal oxide, and methods for their preparation.
    [Show full text]
  • Reproductive MEDICINE Approximately One in Six Couples Will Experience Difficulty Conceiving
    reproductive MEDICINE Approximately one in six couples will experience difficulty conceiving. Our team can help. Welcome to the CMC Center for Reproductive Medicine at CMC Women’s Institute. From the moment you enter our office, you will experience the warm and welcoming atmosphere, the expert medical care and the success that truly makes the CMC Center for Reproductive Medicine one of the best centers in the region. Our physicians have over 50 years combined experience and are the only all board-certified Reproductive Endocrinology and Infertility team near Charlotte. Whether your infertility issue is simple or complex, our caring team will do everything it can to help you achieve your dream of having a baby. “The nurses are your biggest cheerleaders, and the doctors are your rock which helps you through to the next steps. Whenever I see my girls smile and giggle, every shot, test and office visit suddenly becomes a part of the story of how our family was created. There are no words to express my gratitude for the doctors and staff at CMC Center for Reproductive Medicine.” -Melissa Harrison Highly Trained When “high tech” treatment is needed, our physicians provide comprehensive care, seeking out the most effective new technologies with the best trained andrology and embryology specialists in the region. Our services include: Fertility Services • Intrauterine sperm inseminations (IUI) We believe that open communication is one of the most important elements of fertility • In vitro fertilization (IVF) treatment. This is why our entire staff is committed to listening to your concerns and • Donor egg program keeping you fully informed throughout your entire treatment plan.
    [Show full text]
  • Novel Insights in Commercial in Vitro Embryo Production in Cattle
    Novel insights in commercial in vitro embryo production in cattle Maaike Catteeuw Promoter: Prof. dr. Ann Van Soom Copromoters: Prof. dr. Joris Vermeesch, Dr. Katrien Smits Dissertation submitted to Ghent University in fulfilment of the requirements for the degree of Doctor of Philosophy (PhD) in Veterinary Sciences 2018 Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine Members of the examination committee Prof. dr. Herman Favoreel Chairman – Faculty of Veterinary Medicine, Ghent University, Belgium Prof. dr. Bjorn Heindryckx Faculty of Medicine and Health Sciences, Ghent University, Belgium Prof. dr. Luc Peelman Faculty of Veterinary Medicine, Ghent University, Belgium Prof. dr. Geert Opsomer Faculty of Veterinary Medicine, Ghent University, Belgium Dr. Erik Mullaart CRV BV, the Netherlands Dr. Karen Goossens Research institute for Agriculture, Fisheries and Food (ILVO), Belgium Funding Project G039214N: Chromosomal instability during early embryonic development: elucidating key mechanisms in a bovine model Printed by University Press, Zelzate TABLE OF CONTENTS LIST OF ABBREVIATIONS CHAPTER 1 GENERAL INTRODUCTION 7 1.1 ASSISTED REPRODUCTIVE TECHNOLOGIES IN CATTLE 9 1.2 COMMERCIAL IN VITRO EMBRYO PRODUCTION 11 1.3 QUALITY ASSESSMENT OF EMBRYONIC DEVELOPMENT 25 1.4 GENETIC DISORDERS AND CHROMOSOMAL ABNORMALITIES IN CATTLE 34 1.5 CHROMOSOMAL ABNORMALITIES IN HUMAN EMBRYOS AND THE BOVINE MODEL 35 1.5 REFERENCES 37 CHAPTER 2 AIMS OF THE STUDY 51 CHAPTER 3 HOLDING IMMATURE BOVINE OOCYTES IN A COMMERCIAL
    [Show full text]
  • Reproductive Endocrinology and Infertility the American Board of Obstetrics and Gynecology, Inc
    1 2019 Bulletin for Subspecialty Certification in Reproductive Endocrinology and Infertility The American Board of Obstetrics and Gynecology, Inc. 2915 Vine St., Dallas, TX 75204 First in Women’s Health This Bulletin, issued in January 2018, represents the official statement of the 2019 requirements for subspecialty certification in Reproductive Endocrinology and Infertility 2 Important Information for all Candidates 1. Beginning in calendar year 2020, all physicians who have completed an ABOG or ACGME fellowship in Reproductive Endocrinology and Infertility must achieve ABOG subspecialty certification within 8 years of completion of their training. If certification is not achieved within 8 years, the physician no longer will be eligible to apply for either the qualifying or certifying subspecialty examination unless an additional 6 months of subspecialty training is completed. Physicians who have completed subspecialty training in calendar year 2012 or earlier must be subspecialty certified by 2020 or will be required to complete an additional 6 months of training before regaining eligibility to apply for certification. 2. The preparation of case lists for the Certifying Examination has changed. Candidates will no longer submit paper case lists. Rather, submission will be electronic. Candidates MUST use the electronic reproductive endocrinology and infertility case list forms that will be posted on their ABOG Personal Page in early 2018. 3. Fellows may take up to 8 weeks off each of the fellowship years. The total time off may not exceed 15 weeks over the three years. 4. All fees must be paid by credit card through the ABOG website (www.abog.org) and are payable in US Dollars only.
    [Show full text]
  • Preparation of Polyvinylpyrrolidone Or Vinyl-Pyrrolidone/Vinyl Acetate Copolymers of Various Molecular Weights Using a Single Initiator System
    European Patent Office iy Publication number: 0 104 042 Office europeen des brevets A2 © EUROPEAN PATENT APPLICATION © Application number: 83305356.4 © Int. CI.3: C 08 F 26/10 © Date of filing: 13.09.83 © Priority: 20.09.82 US 419869 © Applicant: GAF CORPORATION 20.09.82 US 419870 140 West 51st Street New York New York 10020(US) © Date of publication of application: © Inventor: Barabas, Eugene S. 28.03.84 Bulletin 84/13 41 Stanie Brae Drive Watchung New Jersey 07060{US) @ Designated Contracting States: CH DE FR GB LI © Inventor: Cho, James R. 50 Powder Mill Lane Oakland New Jersey 07436(US) © Representative: Ford, Michael Frederick et al, MEWBURN ELUS & CO. 213 Cursitor Street London EC4A1BQIGB) © Preparation of polyvinylpyrrolidone or vinyl-pyrrolidone/vinyl acetate copolymers of various molecular weights using a single initiator system. @\sj) Vinylpyrrolidone or vinylpyrrolidone and vinyl acetate monomers are polymerized using free radical initiator con- sisting of t-Butylperoxypivalate and preferably in solvent consisting essentially of water, isopropyl alcohol, sec. butyl alcohol or mixtures thereof to produce polyvinylpyrrolidone or vinylpyrrolidone/vinyl acetate copolymer. CM < CM O o o 0. UJ Croydon Priming Company Ltd Background of the Invention Polymerization of N-vinyl-2-pyrrolidone (vinylpyrrolidone) and vinyl acetate by free radical mechanisms to form vinylpyrrolidone/vinyl acetate copolymer (PVP/VA) is well known and is described for instance in U. S. patent 2,667,473. Polymerization of N-vinyl-2-pyrrolidone (vinylpyrrolidone) by free radical mechanisms to form polyvinylpyrrolidone (PVP) is also well known and is described for instance in U. S. patents 4,058,655, 4,053,696 and 3,862,915.
    [Show full text]
  • Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009†
    Human Reproduction, Vol.24, No.11 pp. 2683–2687, 2009 Advanced Access publication on October 4, 2009 doi:10.1093/humrep/dep343 SIMULTANEOUS PUBLICATION Infertility The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009† F. Zegers-Hochschild1,9, G.D. Adamson2, J. de Mouzon3, O. Ishihara4, R. Mansour5, K. Nygren6, E. Sullivan7, and S. van der Poel8 on behalf of ICMART and WHO 1Unit of Reproductive Medicine, Clinicas las Condes, Santiago, Chile 2Fertility Physicians of Northern California, Palo Alto and San Jose, California, USA 3INSERM U822, Hoˆpital de Biceˆtre, Le Kremlin Biceˆtre Cedex, Paris, France 4Saitama Medical University Hospital, Moroyama, Saitana 350-0495, JAPAN 53 Rd 161 Maadi, Cairo 11431, Egypt 6IVF Unit, Sophiahemmet Hospital, Stockholm, Sweden 7Perinatal and Reproductive Epidemiology and Research Unit, School Women’s and Children’s Health, University of New South Wales, Sydney, Australia 8Department of Reproductive Health and Research, and the Special Program of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland 9Correspondence address: Unit of Reproductive Medicine, Clinica las Condes, Lo Fontecilla, 441, Santiago, Chile. Fax: 56-2-6108167, E-mail: [email protected] background: Many definitions used in medically assisted reproduction (MAR) vary in different settings, making it difficult to standardize and compare procedures in different countries and regions. With the expansion of infertility interventions worldwide, including lower resource settings, the importance and value of a common nomenclature is critical. The objective is to develop an internationally accepted and continually updated set of definitions, which would be utilized to standardize and harmonize international data collection, and to assist in monitoring the availability, efficacy, and safety of assisted reproductive technology (ART) being practiced worldwide.
    [Show full text]
  • Parviz K. Kavoussi, M.D., F.A.C.S. Reproductive Urologist
    PARVIZ K. KAVOUSSI, M.D., F.A.C.S. REPRODUCTIVE UROLOGIST www.AustinFertility.com www.AustinVasecomyCenter.com www.WestlakeIVF.com www.AustinMensHealth.com WESTLAKE LOCATION: 300 BEARDSLEY LANE Building B, SUITE 200 AUSTIN, TX 78746 SOUTH AUSTIN LOCATION: 4303 JAMES CASEY, SUITE B AUSTIN, TEXAS 78745 ROUND ROCK LOCATION: 7700 CAT HOLLOW DRIVE, SUITE 106 ROUND ROCK, TEXAS 78681 Phone: (512) 444-1414 EXT 2 Fax: (512) 441-1202 POSTDOCTORAL TRAINING THE UNIVERSITY OF VIRGINIA HEALTH SCIENCES CENTER. Charlottesville, Virginia. Fellowship- Reproductive Urology/Andrology – Male Infertility, Sexual Medicine, and Microsurgery (Vasectomy Reversals/Sperm Retrievals). National Institute of Health funded fellow. July 2008-June 2010. BAYLOR SCOTT & WHITE MEMORIAL HOSPITAL AND HEALTH SCIENCES CENTER. Temple, Texas. Residency- Urology- July 2004-June 2008. General Surgery July 2002-June 2004 EDUCATION THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON. Galveston, Texas. Doctor of Medicine. August 1998-May 2002. BAYLOR UNIVERSITY. Waco, Texas. Bachelor of Arts, degree in Biology. August 1994-May 1998. BOARD CERTIFICATION The American Board of Urology ACADEMIC APPOINTMENTS • Adjunct Assistant Professor. Department of Urology. University of Texas Health Sciences Center at San Antonio. September 2015-present. • Adjunct Assistant Professor. Department of Psychology, Division of Neuroendocrinology and Motivation. University of Texas at Austin. March 2013- present. SPECIALTY CREDENTIALS RAMSES. Credentialed in Robot Assisted Microsurgery in Urology/Robot Assisted Vasectomy Reversals by RAMSES (Robot Assisted Microsurgical and Endoscopic Society). Winter Haven Hospital & University of Florida. April 2011. LABORATORY EXPERIENCE • Basic science laboratory research in the Department of Urology at University of Virginia funded via NIH training grant. July 2008-June 2010. • Non-human primate surgery at the Michael E.
    [Show full text]